Company / Capital Expenditures
TG Therapeutics, Inc. Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$214.0K
FY2025
5-year range
$0 / $401.0K
FY2021-FY2025
Trend
+375.6%
vs FY2024
Sector context
#158 of 194
Health Care
What the data says
Capital Expenditures changed +376% YoY in FY2025, a notable deviation from the 8-year average annual change of +2768%.
Based on SEC 10-K filings.
$214,000 in FY2025 with a 5-year CAGR of -9.7%.
Improved from $0 to $214,000 over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +148.2%
- 5-Year CAGR
- -9.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 194This company $214.0K Sector average $117.5M
▼
-99.8% below sector average
Key checks
Key Insights
- 5-year CAGR of -9.7%, indicating a declining trend.
- In FY2025, capital expenditures increased 375.6% year-over-year.
- Ranks #158 out of 194 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $214.0K | +375.6% |
| FY2024 | $45.0K | - |
| FY2023 | $0 | -100.0% |
| FY2022 | $14.0K | -96.5% |
| FY2021 | $401.0K | +12.3% |
| FY2020 | $357.0K | +17750.0% |
| FY2019 | $2.0K | -97.8% |
| FY2018 | $90.0K | +4400.0% |
| FY2017 | $2.0K | -99.4% |
| FY2016 | $344.0K | +714.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026